# Ameresco, Inc.: financial statements, quarterly

AMRC · NYSE · CIK 1488139 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amrc.md) · [Financials](/companies/amrc/financials.md) · [Filings](/companies/amrc/filings.md) · [Insiders](/companies/amrc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amrc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [327](/filings/0001488139-24-000139.md) | [335](/filings/0001488139-24-000176.md) | [441 d](/filings/0001488139-25-000018.md) | [298](/filings/0001488139-25-000094.md) | [438](/filings/0001488139-25-000136.md) | [501](/filings/0001628280-25-048545.md) | [533 d](/filings/0001488139-25-000018.md) | [353](/filings/0001628280-26-030169.md) | [472](/filings/0001628280-26-052190.md) | [526](/filings/0001628280-25-048545.md) | [401](/filings/0001628280-26-030169.md) | [515](/filings/0001628280-26-052190.md) |
| Cost of revenue | $m | [268](/filings/0001488139-24-000139.md) | [271](/filings/0001488139-24-000176.md) | [367 d](/filings/0001488139-25-000018.md) | [251](/filings/0001488139-25-000094.md) | [373](/filings/0001488139-25-000136.md) | [424](/filings/0001628280-25-048545.md) | [466 d](/filings/0001488139-25-000018.md) | [301](/filings/0001628280-26-030169.md) | [399](/filings/0001628280-26-052190.md) | [442](/filings/0001628280-25-048545.md) | [345](/filings/0001628280-26-030169.md) | [424](/filings/0001628280-26-052190.md) |
| Gross profit | $m | [58.6](/filings/0001488139-24-000139.md) | [63.7](/filings/0001488139-24-000176.md) | [74.2 d](/filings/0001488139-25-000018.md) | [47.0](/filings/0001488139-25-000094.md) | [65.2](/filings/0001488139-25-000136.md) | [77.1](/filings/0001628280-25-048545.md) | [66.8 d](/filings/0001488139-25-000018.md) | [51.9](/filings/0001628280-26-030169.md) | [73.4](/filings/0001628280-26-052190.md) | [84.3](/filings/0001628280-25-048545.md) | [56.5](/filings/0001628280-26-030169.md) | [91.3](/filings/0001628280-26-052190.md) |
| Selling, general and administrative | $m | [41.4](/filings/0001488139-24-000139.md) | [42.8](/filings/0001488139-24-000176.md) | [36.7 d](/filings/0001488139-25-000018.md) | [39.6](/filings/0001488139-25-000094.md) | [44.2](/filings/0001488139-25-000136.md) | [42.1](/filings/0001628280-25-048545.md) | [47.8 d](/filings/0001488139-25-000018.md) | [38.5](/filings/0001628280-26-030169.md) | [45.7](/filings/0001628280-26-052190.md) | [43.4](/filings/0001628280-25-048545.md) | [46.3](/filings/0001628280-26-030169.md) | [47.6](/filings/0001628280-26-052190.md) |
| Operating income | $m | [17.6](/filings/0001488139-24-000139.md) | [21.4](/filings/0001488139-24-000176.md) | [34.1 d](/filings/0001488139-25-000018.md) | [8.0](/filings/0001488139-25-000094.md) | [21.0](/filings/0001488139-25-000136.md) | [35.2](/filings/0001628280-25-048545.md) | [44.6 d](/filings/0001488139-25-000018.md) | [13.7](/filings/0001628280-26-030169.md) | [27.8](/filings/0001628280-26-052190.md) | [42.4](/filings/0001628280-25-048545.md) | [10.2](/filings/0001628280-26-030169.md) | [44.2](/filings/0001628280-26-052190.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001488139-24-000139.md) | [(10.1)](/filings/0001488139-24-000176.md) | [(15.1) d](/filings/0001488139-25-000018.md) | [0.0](/filings/0001488139-25-000094.md) | [0.0](/filings/0001488139-25-000136.md) | [(3.3)](/filings/0001628280-25-048545.md) | [(16.7) d](/filings/0001488139-25-000018.md) | [1.2](/filings/0001628280-26-030169.md) | [(2.9)](/filings/0001628280-26-052190.md) | [(3.7)](/filings/0001628280-25-048545.md) | [(3.2)](/filings/0001628280-26-030169.md) | [0.1](/filings/0001628280-26-052190.md) |
| Net income | $m | [6.4](/filings/0001488139-24-000139.md) | [21.3](/filings/0001488139-24-000176.md) | [33.7 d](/filings/0001488139-25-000018.md) | [(2.9)](/filings/0001488139-25-000094.md) | [5.0](/filings/0001488139-25-000136.md) | [17.6](/filings/0001628280-25-048545.md) | [37.1 d](/filings/0001488139-25-000018.md) | [(5.5)](/filings/0001628280-26-030169.md) | [12.9](/filings/0001628280-26-052190.md) | [18.5](/filings/0001628280-25-048545.md) | [(18.3)](/filings/0001628280-26-030169.md) | [9.7](/filings/0001628280-26-052190.md) |
| Diluted EPS | $ per share | [0.12](/filings/0001488139-24-000139.md) | [0.40](/filings/0001488139-24-000176.md) | not reported | [(0.06)](/filings/0001488139-25-000094.md) | [0.09](/filings/0001488139-25-000136.md) | [0.33](/filings/0001628280-25-048545.md) | not reported | [(0.10)](/filings/0001628280-26-030169.md) | [0.24](/filings/0001628280-26-052190.md) | [0.35](/filings/0001628280-25-048545.md) | [(0.35)](/filings/0001628280-26-030169.md) | [0.18](/filings/0001628280-26-052190.md) |
| Basic EPS | $ per share | [0.12](/filings/0001488139-24-000139.md) | [0.41](/filings/0001488139-24-000176.md) | not reported | [(0.06)](/filings/0001488139-25-000094.md) | [0.10](/filings/0001488139-25-000136.md) | [0.34](/filings/0001628280-25-048545.md) | not reported | [(0.10)](/filings/0001628280-26-030169.md) | [0.24](/filings/0001628280-26-052190.md) | [0.35](/filings/0001628280-25-048545.md) | [(0.35)](/filings/0001628280-26-030169.md) | [0.18](/filings/0001628280-26-052190.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [108](/filings/0001488139-23-000172.md) | [79.3](/filings/0001488139-25-000018.md) | [77.7](/filings/0001488139-24-000081.md) | [150](/filings/0001488139-24-000139.md) | [114](/filings/0001488139-24-000176.md) | [109](/filings/0001628280-25-048545.md) | [71.6](/filings/0001488139-25-000094.md) | [81.6](/filings/0001488139-25-000136.md) | [94.6](/filings/0001628280-25-048545.md) | [71.8](/filings/0001628280-26-052190.md) | [104](/filings/0001628280-26-030169.md) | [138](/filings/0001628280-26-052190.md) |
| Current assets | $m | [1,030](/filings/0001488139-23-000172.md) | [1,128](/filings/0001488139-25-000018.md) | [1,126](/filings/0001488139-24-000081.md) | [1,240](/filings/0001488139-24-000139.md) | [1,225](/filings/0001488139-24-000176.md) | [1,301](/filings/0001628280-25-048545.md) | [1,257](/filings/0001488139-25-000094.md) | [1,280](/filings/0001488139-25-000136.md) | [1,420](/filings/0001628280-25-048545.md) | [1,553](/filings/0001628280-26-052190.md) | [1,554](/filings/0001628280-26-030169.md) | [1,680](/filings/0001628280-26-052190.md) |
| Total assets | $m | [3,461](/filings/0001488139-23-000172.md) | [3,714](/filings/0001488139-25-000018.md) | [3,803](/filings/0001488139-24-000081.md) | [3,965](/filings/0001488139-24-000139.md) | [3,982](/filings/0001488139-24-000176.md) | [4,159](/filings/0001628280-25-048545.md) | [4,170](/filings/0001488139-25-000094.md) | [4,295](/filings/0001488139-25-000136.md) | [4,426](/filings/0001628280-25-048545.md) | [4,537](/filings/0001628280-26-052190.md) | [4,641](/filings/0001628280-26-030169.md) | [4,832](/filings/0001628280-26-052190.md) |
| Current liabilities | $m | [882](/filings/0001488139-23-000172.md) | [901](/filings/0001488139-25-000018.md) | [1,162](/filings/0001488139-24-000081.md) | [1,232](/filings/0001488139-24-000139.md) | [965](/filings/0001488139-24-000176.md) | [889](/filings/0001628280-25-048545.md) | [798](/filings/0001488139-25-000094.md) | [822](/filings/0001488139-25-000136.md) | [939](/filings/0001628280-25-048545.md) | [1,029](/filings/0001628280-26-052190.md) | [1,044](/filings/0001628280-26-030169.md) | [1,005](/filings/0001628280-26-052190.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [410](/filings/0001488139-23-000172.md) | [322](/filings/0001488139-25-000018.md) | [539](/filings/0001488139-24-000081.md) | [524](/filings/0001488139-24-000139.md) | [343](/filings/0001488139-24-000176.md) | [149](/filings/0001628280-25-048545.md) | [149](/filings/0001488139-25-000094.md) | [161](/filings/0001488139-25-000136.md) | [167](/filings/0001628280-25-048545.md) | [132](/filings/0001628280-26-052190.md) | [162](/filings/0001628280-26-030169.md) | [164](/filings/0001628280-26-052190.md) |
| Shareholders' equity | $m | [869](/filings/0001488139-23-000172.md) | [902](/filings/0001488139-25-000018.md) | [905](/filings/0001488139-24-000081.md) | [915](/filings/0001488139-24-000139.md) | [937](/filings/0001488139-24-000176.md) | [1,013](/filings/0001628280-25-048545.md) | [1,012](/filings/0001488139-25-000094.md) | [1,035](/filings/0001488139-25-000136.md) | [1,056](/filings/0001628280-25-048545.md) | [1,080](/filings/0001628280-26-052190.md) | [1,065](/filings/0001628280-26-030169.md) | [1,237](/filings/0001628280-26-052190.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(92.6) d](/filings/0001488139-24-000139.md) | [(6.6) d](/filings/0001488139-24-000176.md) | [(29.6) d](/filings/0001488139-25-000018.md) | [20.8](/filings/0001488139-25-000094.md) | [53.3 d](/filings/0001488139-25-000136.md) | [25.1 d](/filings/0001628280-25-048545.md) | [18.4 d](/filings/0001488139-25-000018.md) | [(28.3)](/filings/0001628280-26-030169.md) | [(26.9) d](/filings/0001628280-26-052190.md) | [17.7 d](/filings/0001628280-25-048545.md) | [35.4](/filings/0001628280-26-030169.md) | [(107) d](/filings/0001628280-26-052190.md) |
| Capital expenditure | $m | [1.0 d](/filings/0001488139-24-000139.md) | [1.9 d](/filings/0001488139-24-000176.md) | [1.1 d](/filings/0001488139-25-000018.md) | [1.0](/filings/0001488139-25-000094.md) | [1.1 d](/filings/0001488139-25-000136.md) | [1.0 d](/filings/0001628280-25-048545.md) | [1.2 d](/filings/0001488139-25-000018.md) | [0.4](/filings/0001628280-26-030169.md) | [0.1 d](/filings/0001628280-26-052190.md) | [(0.4) d](/filings/0001628280-25-048545.md) | [0.5](/filings/0001628280-26-030169.md) | [0.9 d](/filings/0001628280-26-052190.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [53.3](/filings/0001488139-23-000172.md) | [53.3](/filings/0001488139-24-000081.md) | [53.2](/filings/0001488139-24-000139.md) | [53.3](/filings/0001488139-24-000176.md) | [52.3](/filings/0001488139-25-000094.md) | [53.1](/filings/0001488139-25-000136.md) | [53.2](/filings/0001628280-25-048545.md) | [52.5](/filings/0001628280-26-030169.md) | [52.8](/filings/0001628280-26-052190.md) | [53.4](/filings/0001628280-25-048545.md) | [52.9](/filings/0001628280-26-030169.md) | [53.8](/filings/0001628280-26-052190.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.